Skip to content

Cardioprotective effects of Electro-acupuncture

Cardioprotective potential of Transcutaneous Electro-Stimulation in Acupuncture points in the preoperative Heart Surgery

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
REBEC
Registry ID
RBR-9g8d46
Enrollment
Unknown
Registered
2018-05-11
Start date
2018-06-01
Completion date
Unknown
Last updated
2025-10-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Cardiovascular surgical procedures.

Interventions

Experimental group: There will be 14 patients of both sexes, adults, hospitalized at the National Institute of Cardiology, preoperative of valve replacement surgery. Eligible patients will undergo a p
Other
E02.331.800
H02.004

Sponsors

Instituto Nacional de Cardiologia
Lead Sponsor
Instituto Nacional de Cardiologia
Collaborator

Eligibility

Inclusion criteria

Inclusion criteria: All patients between 18 and 80 years of age; who undergo an exclusive surgical procedure of valve replacement; and are hospitalized preoperatively at the National Institute of Cardiology will be eligible for the study.

Exclusion criteria

Exclusion criteria: Patients who present in the initial evaluation will be excluded from the study; pregnancy; presence of a cardiac pacing device; intermittent cardiodesfibrillator; hearing devices; skull trauma; brain injury; status epileptics; tetanus; adult respiratory distress syndrome; chronic liver disease; chronic kidney diseases; patients taking Sulfonylurea; Glibenclamide; who have already had previous heart surgery; cognitive alterations that impede the accomplishment of the protocol.

Design outcomes

Primary

MeasureTime frame
Patients who receive Transcutaneous Nerve Stimulation in Acupuncture Points will stimulate a systemic response leading to a cardioprotective effect of this technique, evaluated by means of heart rate variability using a frequency meter, such evaluation will occur during electrostimulation and by reducing the markers of myocardial necrosis, evaluated through laboratory tests collected in the immediate postoperative period of individuals submitted to valve replacement surgery.

Secondary

MeasureTime frame
Expected outcome 1: Preoperative transcutaneous nerve electrostimulation may reduce myocardial necrosis markers in the postoperative period of patients undergoing valve replacement, as assessed by the blood concentration of Troponin 1. Such evaluation will occur with laboratories 6hs, 12hs and 24hs postoperatively;;Expected outcome 2: Transcutaneous nerve stimulation at acupuncture points may be helpful in reducing inotropes in the postoperative period of valve replacement, assessed using the inotropic score collected 6 hours, 12 hours and 24 hours postoperatively;;Expected outcome 3: Transcutaneous nerve stimulation may have influence on cardiovascular autonomic modulation through analysis of heart rate variability through the use of the Polar monitor, which will be evaluated during 40 minutes of electrostimulation with at least 24 hours before surgery;;Expected outcome 4: Preoperative transcutaneous nerve electrostimulation may reduce mortality and length of stay in intensive care patients in the postoperative period of cardiac surgery, assessed by chart analysis. Such assessment will occur on discharge from the patient.

Countries

Brazil

Contacts

Public ContactNayara Goretti

Instituto Nacional de Cardiologia

nayara.30@hotmail.com+55-021-999358695

Outcome results

None listed

Source: REBEC (via WHO ICTRP)